Altimmune to Present at Upcoming Investor Conferences

Rhea-AI Summary

On November 10, 2021, Altimmune, a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker ALT, announced upcoming presentations by its management team at two significant investor conferences.

• Stifel’s 2021 Virtual Healthcare Conference: November 15, 2021, at 10:40 am Eastern Time.
• Jefferies London Healthcare Conference: November 18, 2021, at 8:00 am GMT.

Both sessions will be accessible via the Altimmune website.

News Market Reaction – ALT

+1.47%

+1.47% Session move

In the trading session that priced this news, ALT gained 1.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following investor conferences in November 2021:

• Stifel’s 2021 Virtual Healthcare Conference
  Monday, November 15, 2021
  10:40 am Eastern Time

• Jefferies London Healthcare Conference
  Thursday, November 18, 2021
  8:00 am GMT

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell™).   For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will Brown
Chief Financial Officer
Phone:   240-654-1450
wbrown@altimmune.com

FAQ

What are the dates for Altimmune's upcoming investor presentations in November 2021?

Altimmune will present at Stifel’s 2021 Virtual Healthcare Conference on November 15, 2021, and at Jefferies London Healthcare Conference on November 18, 2021.

What time will Altimmune's presentations take place?

Altimmune's presentation at Stifel’s conference is scheduled for 10:40 am Eastern Time, and at Jefferies London Healthcare Conference, it will be at 8:00 am GMT.

How can I access Altimmune's presentation webcasts?

The presentations can be accessed through the Events section of the Altimmune website.

What is the focus of Altimmune's developments?

Altimmune is focused on developing treatments for obesity and liver diseases, including next-generation peptide therapeutics.

Where can I find more information about Altimmune?

More information about Altimmune can be found on their official website: www.altimmune.com.